Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostatic Neoplasms × Tablets × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 9 Melanoma 4 Multiple Myeloma 3 Skin Neoplasms 2 Venous Thromboembolism 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Skin Toxicity 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Renal Insufficiency 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Polycystic Ovary Syndrome 1 Obesity 1 Neoplasms 1 Myeloproliferative Disorders 1 Meningioma 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Leukemia 1 Inflammation 1 Head and Neck Neoplasms 1

Interventions

Docetaxel 126 Prednisone 111 Abiraterone Acetate 83 Leuprolide 80 enzalutamide 76 Radiotherapy 54 Magnetic Resonance Spectroscopy 51 Goserelin 50 bicalutamide 47 Androgen Antagonists 47 apalutamide 42 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 41 abiraterone 31 Radiosurgery 31 cabazitaxel 28 Specimen Handling 28 Gonadotropin-Releasing Hormone 27 Carboplatin 26 gallium 68 PSMA-11 25 darolutamide 24 Estramustine 23 relugolix 21 luprolide acetate gel depot 21 Metformin 21 Triptorelin Pamoate 19 Radiation 18 Pluvicto 18 Brachytherapy 18 sipuleucel-T 17 radium Ra 223 dichloride 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05265988 2024-07-31

MERIDIAN

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡